Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

NCT01554254 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Cord Blood Transplant
Hematologic Malignancy
Inherited Metabolic Disease

Interventions

DRUG: TXA127

Sponsor

Tarix Pharmaceuticals